News + Filings Transactions
|
Carroll Jill
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/14/2023 | Arcellx, Inc. | | Grant | Stock Option (right to buy) | 11.5k | $37.94 | $434.8k | | 06/14/2023 |
| 06/01/2023 | Arcellx, Inc. | | Sale | Common Stock | 25.6k | $44.35 | $1.1M | See Note 1 | 05/31/2023 |
| 05/31/2023 | Arcellx, Inc. | | Sale | Common Stock | 315.2k | $41.50 | $13.1M | See Note 1 | 05/31/2023 |
| 05/11/2023 | Arcellx, Inc. | | Sale | Common Stock | 6.5k | $46.15 | $299.3k | See Note 2 | 05/11/2023 |
| 05/11/2023 | Arcellx, Inc. | | Sale | Common Stock | 631.9k | $45.00 | $28.4M | See Note 2 | 05/11/2023 |
| 02/08/2022 | Arcellx, Inc. | | Conversion | Series C Preferred Stock | 433.2k | $0.00 | $0 | See footnote | 02/08/2022 |
| 02/08/2022 | Arcellx, Inc. | | Conversion | Series C Preferred Stock | 649.8k | $0.00 | $0 | See footnote | 02/08/2022 |
| 02/08/2022 | Arcellx, Inc. | | Conversion | Series B-2 Preferred Stock | 533.4k | $0.00 | $0 | See footnote | 02/08/2022 |
| 02/08/2022 | Arcellx, Inc. | | Conversion | Series B-1 Preferred Stock | 666.7k | $0.00 | $0 | See footnote | 02/08/2022 |
| 02/08/2022 | Arcellx, Inc. | | Conversion | Series A Preferred Stock | 1.6M | $0.00 | $0 | See footnote | 02/08/2022 |
| 02/08/2022 | Arcellx, Inc. | | Purchase | Common Stock | 1.6M | $15.00 | $24M | See footnote | 02/08/2022 |
| 02/08/2022 | Arcellx, Inc. | | Conversion | Common Stock | 433.2k | $0.00 | $0 | See footnote | 02/08/2022 |
| 02/08/2022 | Arcellx, Inc. | | Purchase | Common Stock | 66.7k | $15.00 | $1M | See footnote | 02/08/2022 |
| 02/08/2022 | Arcellx, Inc. | | Conversion | Common Stock | 3.4M | $0.00 | $0 | See footnote | 02/08/2022 |
| 04/01/2021 | Pandion Therapeutics, Inc. | PAND | Other | Common Stock | 5.7M | $60.00 | $340.5M | See footnote | 04/01/2021 |
| 04/01/2021 | Pandion Therapeutics, Inc. | PAND | Disposition | Employee Stock Option (Right to Buy) | 14k | $18.00 | $251.9k | | 04/01/2021 |
| 07/21/2020 | Pandion Therapeutics, Inc. | PAND | Purchase | Common Stock | 361.1k | $18.00 | $6.5M | See Footnote | 07/17/2020 |
| 07/21/2020 | Pandion Therapeutics, Inc. | PAND | Conversion | Series A Preferred Stock | 7.8M | $0.00 | $0 | See Footnote | 07/17/2020 |
| 07/21/2020 | Pandion Therapeutics, Inc. | PAND | Conversion | Series B Preferred Stock | 1.8M | $0.00 | $0 | See Footnote | 07/17/2020 |
| 07/21/2020 | Pandion Therapeutics, Inc. | PAND | Conversion | Common Stock | 1.5M | $0.00 | $0 | See Footnote | 07/17/2020 |
| 07/21/2020 | Pandion Therapeutics, Inc. | PAND | Conversion | Common Stock | 348.5k | $0.00 | $0 | See Footnote | 07/17/2020 |
| 07/17/2020 | Pandion Therapeutics, Inc. | PAND | Grant | Stock Option (right to buy) | 14k | $18.00 | $251.9k | See Footnote | 07/17/2020 |
|